Related Experiment Video
Updated: Feb 10, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Flow Cytometric Analysis of Nucleoside Transporters Activity in Chemoresistant Prostate Cancer Model
Background:
Nucleoside analogues represent a relevant class of antimetabolites used for therapy of various types of cancer. However, their effectivity is limited by drug resistance. The nucleoside transport capability of tumour cells is considered to be a determinant of the clinical outcome of treatment regimens using antimetabolites. Due to hydrophilic properties of antimetabolites, their transport across the plasma membrane is mediated by two families of transmembrane proteins, the SLC28 family of cation-linked concentrative nucleoside transporters (hCNTs) and SLC29 family of energy-independent equilibrative nucleoside transporters (hENTs). Loss of functional nucleoside transporters has been associated with reduced efficacy of antimetabolites and their derivatives and treatment failure in diverse malignancies including solid tumours, such as pancreatic adenocarcinoma.
Material And Methods:
The effectivity and kinetics of antimetabolite uptake were analysed using control and docetaxel-resistant PC3 cells. For this purpose, fluorescent nucleoside analogue probe uridine-furane and inhibitor of nucleoside transporters, S-(4-nitrobenzyl) -6-thioinosine were exploited. Combination of flow cytometry, confocal microscopy and real-time quantitative polymerase chain reaction methodology were used for the analysis.
Results:
Here we utilized flow cytometric assay for analysis of nucleoside transporters activity employing fluorescent nucleoside analogue, uridine-furane. We have determined the long-time kinetics of uridine-furane incorporation and quantified its levels in the parental prostate cancer cell line PC3 and its chemoresistant derivative. Finally, we have shown an association between the activity and mRNA expression of nucleoside transporters and sensitivity to various nucleoside analogues.
Conclusion:
Fluorescent techniques can serve as an effective tool for the detection of nucleoside transporter activity which has the potential for application in clinical oncology.Key words: nucleoside transporter proteins - drug resistance - prostatic neoplasm - chemotherapy.
Insights
Drug resistance in cancer limits nucleoside analogue effectiveness. This study shows fluorescent probes can detect nucleoside transporter activity, linking it to drug sensitivity in prostate cancer cells.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Nucleoside analogues are vital antimetabolites for cancer therapy, but drug resistance diminishes their efficacy.
- Tumor cell nucleoside transport, mediated by SLC28 (hCNTs) and SLC29 (hENTs) families, is crucial for antimetabolite uptake and treatment success.
- Reduced nucleoside transporter function is linked to treatment failure in various cancers, including pancreatic adenocarcinoma and prostate cancer.
Purpose of the Study:
- To investigate the role of nucleoside transporters in chemoresistance.
- To evaluate the utility of fluorescent nucleoside analogues for assessing transporter activity.
- To establish a link between nucleoside transporter expression/activity and sensitivity to nucleoside analogues in prostate cancer.
Main Methods:
- Utilized flow cytometry with the fluorescent nucleoside analogue uridine-furane to analyze nucleoside transporter activity.
- Employed docetaxel-resistant PC3 prostate cancer cells and their parental line for comparative analysis.
- Combined flow cytometry, confocal microscopy, and qRT-PCR to quantify transporter activity and mRNA expression.
Main Results:
- Quantified the long-term kinetics of uridine-furane incorporation in PC3 cells and their resistant derivatives.
- Demonstrated an association between nucleoside transporter activity and mRNA expression levels.
- Showed a correlation between transporter status and sensitivity to various nucleoside analogues.
Conclusions:
- Fluorescent techniques offer an effective method for detecting nucleoside transporter activity.
- Nucleoside transporter activity is a potential biomarker for predicting response to nucleoside analogue chemotherapy.
- This approach holds promise for clinical oncology applications in managing drug resistance.
Related Concept Videos
Secondary Active Transport
Secondary Active Transport
Primary Active Transport
Primary Active Transport
Active Transport
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Facilitated Transport

